Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3187 |
|
| Actual shortage: | 257 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2919 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Resolved | 2023-06-16 | 2023-08-17 | 195072 |
| TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Resolved | 2023-06-20 | 2023-08-18 | 195900 |
| TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Actual shortage | 2025-01-30 | 2025-01-30 | 249179 |
| TEVA-ACEBUTOLOL | 100MG | TABLET | Resolved | 2018-05-22 | 2019-08-20 | 50023 |
| TEVA-ACEBUTOLOL | 200MG | TABLET | Resolved | 2018-05-22 | 2019-08-20 | 50026 |
| TEVA-ACEBUTOLOL | 400MG | TABLET | Resolved | 2018-05-22 | 2019-08-20 | 50029 |
| TEVA-ACEBUTOLOL | 200MG | TABLET | Resolved | 2021-11-25 | 2022-01-07 | 149937 |
| TEVA-ACEBUTOLOL | 400MG | TABLET | Resolved | 2023-04-27 | 2023-11-03 | 190743 |
| TEVA-ACEBUTOLOL | 100MG | TABLET | Resolved | 2023-04-27 | 2023-10-26 | 190764 |
| TEVA-ACEBUTOLOL | 400MG | TABLET | Resolved | 2023-06-16 | 2023-07-05 | 195142 |
| TEVA-ACEBUTOLOL | 100MG | TABLET | Resolved | 2023-06-16 | 2023-07-06 | 195237 |
| TEVA-ACYCLOVIR | 400MG | TABLET | Resolved | 2017-11-16 | 2018-11-09 | 29444 |
| TEVA-ACYCLOVIR | 400MG | TABLET | Resolved | 2019-08-22 | 2019-10-04 | 92137 |
| TEVA-ACYCLOVIR | 200MG | TABLET | Resolved | 2020-07-16 | 2020-07-30 | 120450 |
| TEVA-ACYCLOVIR | 400MG | TABLET | Resolved | 2020-08-20 | 2025-04-29 | 122712 |
| TEVA-ACYCLOVIR | 200MG | TABLET | Resolved | 2021-06-03 | 2025-04-29 | 140402 |
| TEVA-ACYCLOVIR | 800MG | TABLET | Resolved | 2021-11-25 | 2025-04-29 | 149928 |
| TEVA-ALENDRONATE | 70MG | TABLET | Resolved | 2017-05-23 | 2017-09-19 | 10886 |
| TEVA-ALENDRONATE | 70MG | TABLET | Resolved | 2018-03-16 | 2018-10-11 | 43116 |
| TEVA-ALENDRONATE | 70MG | TABLET | Resolved | 2019-08-22 | 2019-11-01 | 92174 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |